Company: ATHE
Filing Date: 2025-08-29
Form Type: 20-F
Source: 0001213900-25-082027
Chunk: 63

Company: ALTERITY THERAPEUTICS LTD
Filing Date: 2025-08-29
Form: 20-F
Item: Item 4A
Chunk 63
---
ITEM 4A. UNRESOLVED STAFF
COMMENTS

Not applicable.

ITEM
5. Operating and FINANCIAL review and Prospects

The following discussion and analysis includes
certain forward-looking statements with respect to the business, financial condition and results of operations of our company. The words
“estimate,” “project,” “intend,” “expect” and similar expressions are intended to identify
forward-looking statements within the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to
risks and uncertainties that could cause actual results to differ materially from those contemplated by such forward-looking statements,
including those risk factors contained in Item 3. D. of this annual report. You should read the following discussion and analysis in conjunction
with our consolidated financial statements and the notes thereto included in this annual report.

  Operating Results  
 ─────────────────────

Background